{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-1998-D-0025\" sorted by posted_date descending", "rows": [["FDA-1998-D-0025-0036", "FDA", "FDA-1998-D-0025", "Guidance on Current Good Manufacturing Practice for Positron Emission Tomography Drugs; Availability", "Notice", "NAD-Notice of Availability of Data", "2009-12-10T05:00:00Z", 2009, 12, "2009-12-10T05:00:00Z", null, "2024-11-12T04:49:38Z", "E9-29286", 1, 0, "0900006480a6845a"], ["FDA-1998-D-0025-0037", "FDA", "FDA-1998-D-0025", "Guidance on Pet Drugs --- Current Good Manufacturing Practice (CGMP) - GDL", "Other", "GDL-Guidance (Supporting and Related Materials)", "2009-12-10T05:00:00Z", 2009, 12, "2009-12-10T05:00:00Z", null, "2024-11-07T22:11:10Z", null, 1, 0, "0900006480a686eb"], ["FDA-1998-D-0025-0035", "FDA", "FDA-1998-D-0025", "FDA/CDER Public Meeting on Current Good Manufacturing Practices Regulation and Guidance for PET Drugs, May 21, 2002 - Transcript", "Other", "TR-Transcript", "2009-05-04T04:00:00Z", 2009, 5, "2009-05-04T04:00:00Z", null, "2013-08-11T04:18:35Z", null, 0, 0, "0900006480564782"], ["FDA-1998-D-0025-0030", "FDA", "FDA-1998-D-0025", "Informal Discussion Between the Institute for Clinical PET and FDA - \"Discussion of Literature Review of Safety and Efficacy Data for PET: O-Water and F-Fluorodopa, July 28, 2000\"] - Participant List", "Other", "LST-List", "2009-05-04T04:00:00Z", 2009, 5, "2009-05-04T04:00:00Z", null, "2009-05-04T06:20:04Z", null, 0, 0, "0900006480564711"], ["FDA-1998-D-0025-0031", "FDA", "FDA-1998-D-0025", "Institute for Clinical PET - \"F-DOPA [Master Index]\" - List", "Other", "LST-List", "2009-05-04T04:00:00Z", 2009, 5, "2009-05-04T04:00:00Z", null, "2013-08-11T04:18:35Z", null, 0, 0, "0900006480564713"], ["FDA-1998-D-0025-0029", "FDA", "FDA-1998-D-0025", "Agenda - Informal Discussion Between the Institute for Clinical PET and FDA - \"Discussion of Literature Review of Safety and Efficacy Data for PET: O-Water and F-Fluorodopa, July 28, 2000\" - List", "Other", "LST-List", "2009-05-04T04:00:00Z", 2009, 5, "2009-05-04T04:00:00Z", null, "2013-07-27T21:41:01Z", null, 0, 0, "090000648056470e"], ["FDA-1998-D-0025-0033", "FDA", "FDA-1998-D-0025", "Informal Discussion Between the Institute for Clinical PET and FDA, July 28, 2000 (Pages 1-100) - Transcript", "Other", "TR-Transcript", "2009-05-04T04:00:00Z", 2009, 5, "2009-05-04T04:00:00Z", null, "2013-07-27T21:41:01Z", null, 0, 0, "090000648056471e"], ["FDA-1998-D-0025-0032", "FDA", "FDA-1998-D-0025", "Institute for Clinical PET - \"O-Water Literatures - 2nd Cycle Master Index, July 25, 2000\" - List", "Other", "LST-List", "2009-05-04T04:00:00Z", 2009, 5, "2009-05-04T04:00:00Z", null, "2009-05-04T06:20:07Z", null, 0, 0, "0900006480564716"], ["FDA-1998-D-0025-0034", "FDA", "FDA-1998-D-0025", "Informal Discussion Between the Institute for Clinical PET and FDA, July 28, 2000 (Pages 101-188) - Transcript", "Other", "TR-Transcript", "2009-05-04T04:00:00Z", 2009, 5, "2009-05-04T04:00:00Z", null, "2013-08-11T04:18:35Z", null, 0, 0, "0900006480564719"], ["FDA-1998-D-0025-0011", "FDA", "FDA-1998-D-0025", "FDA/CDER to Institute for Clinical PET - [Meeting Between the Institute for Clinical PET and FDA Staff On Approval Procedures for PET Drugs, February 18-19, 1999] - Letter", "Other", "LST-List", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-07-27T21:41:00Z", null, 0, 0, "0900006480564630"], ["FDA-1998-D-0025-0012", "FDA", "FDA-1998-D-0025", "FDA/CDER to Institute for Clinical PET - \"Existing Reglatory Framework for Drug Approval\" - [Meeting Between the Institute for Clinical PET and FDA Staff On Approval Procedures for PET Drugs, February 18-19, 1999] - Overview", "Other", "LST-List", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-07-27T21:41:00Z", null, 0, 0, "0900006480564632"], ["FDA-1998-D-0025-0017", "FDA", "FDA-1998-D-0025", "Meeting Between the Institute for Clinical PET and FDA Staff On Approval Procedures for PET Drugs, February 19, 1999 - Transcript", "Other", "TR-Transcript", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-08-11T04:18:35Z", null, 0, 0, "0900006480564651"], ["FDA-1998-D-0025-0015", "FDA", "FDA-1998-D-0025", "Draft Model Appliction to Manufacture Fludeoxyglucose F-18 Unjection for Marketing\" - [Meeting Between the Institute for Clinical PET and FDA Staff On Approval Procedures for PET Drugs, February 18-19, 1999]", "Other", "LST-List", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2009-05-04T01:18:32Z", null, 0, 0, "090000648056463f"], ["FDA-1998-D-0025-0006", "FDA", "FDA-1998-D-0025", "FDA/CDER Response to UCLA School of Medicine - Letter", "Other", "LET-Letter", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-07-27T21:41:00Z", null, 0, 0, "090000648056460e"], ["FDA-1998-D-0025-0020", "FDA", "FDA-1998-D-0025", "Supplement to Agenda - \"Meeting Between the Institute for Clinical PET and FDA Staff On Approval Procedures for PET Drugs, February 19, 1999\" - Participant List", "Other", "SUP-Supplement", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2009-05-04T02:21:08Z", null, 0, 0, "0900006480564658"], ["FDA-1998-D-0025-0009", "FDA", "FDA-1998-D-0025", "FDA/CDER and Institute for Clinical PET - TeleConference Call Minutes", "Other", "MT-Memorandum of Telephone Conversation", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-07-27T21:41:00Z", null, 0, 0, "0900006480564624"], ["FDA-1998-D-0025-0021", "FDA", "FDA-1998-D-0025", "Meeting Between FDA/CDER and Institute for Clinical PET - \"Informal Discussion of PET Drugs: Development of Current Good Manufacturing Practices and Approval Procedures\" - List", "Other", "LST-List", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-08-11T02:45:19Z", null, 0, 0, "09000064805646ed"], ["FDA-1998-D-0025-0028", "FDA", "FDA-1998-D-0025", "Informal Discussion Between the Institute for Clinical PET and FDA Development of Current Good Manufacturing Practices and Approval Procedures for PET Drugs, September 28, 1999 \" - Transcript (Pages 201-243)", "Other", "TR-Transcript", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2009-05-04T02:24:34Z", null, 0, 0, "0900006480564706"], ["FDA-1998-D-0025-0026", "FDA", "FDA-1998-D-0025", "Model Application to Manufacture Sodium Fluoride F-18 Injection for Marketing, September 20, 1999 - [Informal Discussion Between the Institute for Clinical PET and FDA Development of Current Good Manufacturing Practices and Approval Procedures for PET Drugs, September 28, 1999 \" - Transcript]", "Supporting & Related Material", "LST- List", "2009-05-03T04:00:00Z", 2009, 5, null, null, "2009-05-04T02:31:48Z", null, 0, 0, "09000064805646e9"], ["FDA-1998-D-0025-0005", "FDA", "FDA-1998-D-0025", "FDA/CDER Response to U.S. Pharmacopeial (USP) - Letter", "Other", "LET-Letter", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-07-27T21:40:59Z", null, 0, 0, "090000648056460b"], ["FDA-1998-D-0025-0007", "FDA", "FDA-1998-D-0025", "FDA/CDER and Institute for Clinical PET - Conference Call Minutes", "Other", "MM-Memorandum of Meeting", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-08-11T02:45:19Z", null, 0, 0, "0900006480564612"], ["FDA-1998-D-0025-0024", "FDA", "FDA-1998-D-0025", "Informal Discussion Between the Institute for Clinical PET and FDA Development of Current Good Manufacturing Practices and Approval Procedures for PET Drugs, September 28, 1999 \" - Transcript (Pages 101-200)", "Other", "TR-Transcript", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-07-27T21:41:01Z", null, 0, 0, "0900006480564709"], ["FDA-1998-D-0025-0013", "FDA", "FDA-1998-D-0025", "Draft Outline for Positron Emission Tomography (PET) CGMPs - [Meeting Between the Institute for Clinical PET and FDA Staff On Approval Procedures for PET Drugs, February 18-19, 1999]", "Other", "LST-List", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2009-05-04T01:18:29Z", null, 0, 0, "0900006480564639"], ["FDA-1998-D-0025-0008", "FDA", "FDA-1998-D-0025", "FDA/CDER Response to UCLA School of Medicine - Letter", "Other", "LET-Letter", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-07-28T01:45:18Z", null, 0, 0, "0900006480564615"], ["FDA-1998-D-0025-0023", "FDA", "FDA-1998-D-0025", "Informal Discussion Between the Institute for Clinical PET and FDA Development of Current Good Manufacturing Practices and Approval Procedures for PET Drugs, September 28, 1999 \" - Transcript (Pages 1-100)", "Other", "TR-Transcript", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-07-27T21:41:01Z", null, 0, 0, "0900006480564701"], ["FDA-1998-D-0025-0027", "FDA", "FDA-1998-D-0025", "Model Application to Manufacture Fludeoxyglucose F-18 Injection for Marketing, September 20, 1999 - [Informal Discussion Between the Institute for Clinical PET and FDA Development of Current Good Manufacturing Practices and Approval Procedures for PET Drugs, September 28, 1999 \" - Transcript]", "Supporting & Related Material", "LST- List", "2009-05-03T04:00:00Z", 2009, 5, null, null, "2009-05-04T02:30:32Z", null, 0, 0, "09000064805646f6"], ["FDA-1998-D-0025-0016", "FDA", "FDA-1998-D-0025", "Meeting Between the Institute for Clinical PET and FDA Staff On Approval Procedures for PET Drugs, February 18, 1999 - Transcript", "Other", "TR-Transcript", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-07-27T21:41:00Z", null, 0, 0, "090000648056464b"], ["FDA-1998-D-0025-0022", "FDA", "FDA-1998-D-0025", "Agenda - \"Informal Discussion Between the Institute for Clinical PET and FDA Development of Current Good Manufacturing Practices and Approval Procedures for PET Drugs, September 28, 1999 \" - List", "Other", "LST-List", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2009-05-04T02:21:11Z", null, 0, 0, "09000064805646fa"], ["FDA-1998-D-0025-0014", "FDA", "FDA-1998-D-0025", "Agenda - \"Meeting Between the Institute for Clinical PET and FDA Staff On Approval Procedures for PET Drugs, February 18-19, 1999\" - List", "Other", "LST-List", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-07-28T01:45:18Z", null, 0, 0, "090000648056463d"], ["FDA-1998-D-0025-0025", "FDA", "FDA-1998-D-0025", "Model Application to Manufacture Ammonia N-13 Injection for Marketing, September 20, 1999 - [Informal Discussion Between the Institute for Clinical PET and FDA Development of Current Good Manufacturing Practices and Approval Procedures for PET Drugs, September 28, 1999 \" - Transcript]", "Supporting & Related Material", "LST- List", "2009-05-03T04:00:00Z", 2009, 5, null, null, "2009-05-04T02:26:53Z", null, 0, 0, "09000064805646e7"], ["FDA-1998-D-0025-0004", "FDA", "FDA-1998-D-0025", "Draft Guidance an Current Good Manufacturing Practice for Positron Emission Tomography Drug Products; Availability [NAD1]", "Notice", "NAD-Notice of Availability of Data", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", "2002-06-06T03:59:59Z", "2009-05-04T06:59:32Z", null, 0, 0, "090000648056473f"], ["FDA-1998-D-0025-0018", "FDA", "FDA-1998-D-0025", "Attachment - F-18 FDG PET in Onocology Safety and Effectiveness Review - [Meeting Between the Institute for Clinical PET and FDA Staff On Approval Procedures for PET Drugs, February 18-19, 1999]", "Supporting & Related Material", "LST- List", "2009-05-03T04:00:00Z", 2009, 5, null, null, "2009-05-04T01:18:46Z", null, 0, 0, "0900006480564642"], ["FDA-1998-D-0025-0019", "FDA", "FDA-1998-D-0025", "FDA/CDER to Institute for Clinical PET - \"Outline of Existing Reglatory Framework for Drug Approval\" - [Meeting Between the Institute for Clinical PET and FDA Staff On Approval Procedures for PET Drugs, February 18-19, 1999] - Outline", "Other", "LST-List", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2009-05-04T01:20:00Z", null, 0, 0, "0900006480564647"], ["FDA-1998-D-0025-0010", "FDA", "FDA-1998-D-0025", "Institute for Clinical Pet and FDA/CDER - \"Informal Discussion of Literature Reviews of Safety and Efficacy For FDG Oncology Indications; Approval Procedure Development Update.... February 18-19, 1999\" - Memorandum", "Other", "M-Memorandum", "2009-05-03T04:00:00Z", 2009, 5, "2009-05-03T04:00:00Z", null, "2013-07-27T21:41:00Z", null, 0, 0, "0900006480564629"], ["FDA-1998-D-0025-0001", "FDA", "FDA-1998-D-0025", "Draft Guidance an Current Good Manufacturing Practice for Positron Emission Tomography Drug Products; Availability [NAD2]", "Notice", "NAD-Notice of Availability of Data", "2005-09-20T04:00:00Z", 2005, 9, "2005-09-15T04:00:00Z", "2005-12-20T04:59:59Z", "2009-05-04T06:59:04Z", null, 0, 0, "090000648056458e"], ["FDA-1998-D-0025-0002", "FDA", "FDA-1998-D-0025", "Guidance PET Drug Products \u2013 Current Good Manufacturing Practice (CGMP) - Draft Guidance", "Supporting & Related Material", "GDL-Guidance", "2005-09-20T04:00:00Z", 2005, 9, null, null, "2009-05-04T07:25:51Z", null, 0, 0, "0900006480564784"], ["FDA-1998-D-0025-0003", "FDA", "FDA-1998-D-0025", "Guidance PET Drug Products \u2013 Current Good Manufacturing Practice (CGMP) - Draft Guidance", "Other", "GDL-Guidance (Supporting and Related Materials)", "2005-09-20T04:00:00Z", 2005, 9, null, null, "2009-05-04T07:23:27Z", null, 0, 0, "0900006480564787"]], "truncated": false, "filtered_table_rows_count": 37, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-1998-D-0025"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1998-D-0025", "results": [{"value": "FDA", "label": "FDA", "count": 37, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1998-D-0025", "results": [{"value": "Other", "label": "Other", "count": 29, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&document_type=Other", "selected": false}, {"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 5, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-1998-D-0025", "results": [{"value": 2009, "label": 2009, "count": 34, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&posted_year=2009", "selected": false}, {"value": 2005, "label": 2005, "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&posted_year=2005", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&_facet=comment_start_date"}, {"name": "last_modified", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&_facet=last_modified"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-1998-D-0025&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 2223.836299031973, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}